Insulgen 40IU Injection

Insulgen 40 IU Injection is a short-acting human insulin designed to manage postprandial blood glucose in patients with diabetes mellitus. It provides rapid glucose-lowering effects, supporting safe and effective glycemic control in adults and children.

Available Models/Sizes/Variations

• Vial size: 1 mL containing 40 IU insulin
• Concentration: 40 IU/mL

Main Intended Uses (with localized benefits)

• Short-term glycemic control for type 1 diabetes
• Supplementary insulin for type 2 diabetes
• Supports safe diabetes management in Tanzanian homes and clinics

Operating Instructions

1. Inspect vial; solution should be clear and colorless.
2. Administer subcutaneously using sterile syringe or pen before meals.
3. Rotate injection sites to prevent lipodystrophy.
4. Adjust dose according to blood glucose monitoring and medical advice.
5. Discard vial 4 weeks after first use.

Potential Risks / Adverse Events

• Hypoglycemia (low blood sugar)
• Injection site reactions (redness, swelling)
• Weight gain or rare allergic reactions

Interactions / Compatibility

• May interact with oral antidiabetic drugs, corticosteroids, beta-blockers, ACE inhibitors, or other medications affecting blood sugar.

Warnings / Precautions (with localized warnings)

• Store in refrigerator at 2–8°C; do not freeze.
• Do not mix with other insulins unless prescribed by a doctor.
• Monitor blood glucose levels regularly.
• Keep out of reach of children.

Quick Device Facts Table

Item	Detail
Device Type	Short-acting human insulin
Intended Use	Postprandial blood sugar control
Operating Environment	Home or clinic; subcutaneous injection
Sterilization Method	Single-use syringe or pen required
Potential Risks	Hypoglycemia, injection site reactions
Warnings	Store 2–8°C; discard after 4 weeks

Mechanism of Operation